ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $0

      Shares

      0

      % of Portfolio

      0.00%

      Average Buy Price

      $14.4

      Avg closing price
      Price range

      12 Third Avenue Management Veradigm Trades

      Third Avenue Management started to build up the position in Veradigm in Q2 2013 and continued to invest until Q2 2014. Since then they sold 2.03M shares. The investor completely sold their stake between Q3 2014 and Q1 2017.

      Avg closing price
      Price range
      Sold -204k shares Q1 2017
      Avg closing price $11.86
      Price range $10.53 - $12.82
      Sold 0.3% shares (-664 shares) Q4 2016
      Avg closing price $11.41
      Price range $10.00 - $13.38
      Sold 31.3% shares (-93.2k shares) Q1 2016
      Avg closing price $13.13
      Price range $12.08 - $14.65
      Sold 0.1% shares (-193 shares) Q4 2015
      Avg closing price $14.34
      Price range $12.30 - $15.53
      Sold 51.7% shares (-318k shares) Q3 2015
      Avg closing price $13.76
      Price range $12.20 - $15.16
      Sold 68.1% shares (-1.31M shares) Q4 2014
      Avg closing price $12.73
      Price range $11.23 - $13.86
      Sold 4.7% shares (-95k shares) Q3 2014
      Avg closing price $15.15
      Price range $13.40 - $16.81
      Increased shares by 18.6% (+317k shares) Q2 2014
      Avg closing price $15.59
      Price range $14.44 - $18.29
      Increased shares by 11.3% (+173k shares) Q1 2014
      Avg closing price $17.30
      Price range $14.71 - $19.43
      Increased shares by 11.2% (+155k shares) Q4 2013
      Avg closing price $14.74
      Price range $13.83 - $15.46
      Increased shares by 22.0% (+249k shares) Q3 2013
      Avg closing price $15.05
      Price range $13.12 - $16.26
      New holding (+1.13M shares) Q2 2013
      Avg closing price $13.40
      Price range $12.58 - $14.09

      News about Veradigm Inc and Third Avenue Management

      MedEvolve Announces Strategic Marketing Relationship with Veradigm to Enhance Revenue Cycle Management Solutions for Healthcare Organizations

      MedEvolve Announces Strategic Marketing Relationship with Veradigm to Enhance Revenue Cycle Management Solutions for Healthcare Organizations

      LITTLE ROCK, Ark.--(BUSINESS WIRE)--MedEvolve, a leading provider of effective intelligence technology that provides, automation, transparency and accountabi...

      businesswire.com businesswire.com, over 1 year ago
      Veradigm Network Solution Practice Fusion EHR Receives Top Ambulatory Rankings

      Veradigm Network Solution Practice Fusion EHR Receives Top Ambulatory Rankings

      CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm? (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black B...

      businesswire.com businesswire.com, over 1 year ago
      Veradigm''s (MDRX) New Management Team Reduces Guidance Amid Class Action Lawsuit Alleging Accounting Fraud - Hagens Berman

      Veradigm''s (MDRX) New Management Team Reduces Guidance Amid Class Action Lawsuit Alleging Accounting Fraud - Hagens Berman

      SAN FRANCISCO, Jan. 14, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Veradigm Inc. (NASDAQ: MDRX ) investors who suffered substantial losses to submit your l...

      Benzinga Benzinga, over 1 year ago
      Veradigm (MDRX) Faces Securities Fraud Lawsuit Alleging Accounting Fraud, New Management Team Reduces Guidance- Hagens Berman

      Veradigm (MDRX) Faces Securities Fraud Lawsuit Alleging Accounting Fraud, New Management Team Reduces Guidance- Hagens Berman

      HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages MDRX Investors with Substantial Losses to Contact Firm Before Jan. 22nd Deadline HAGENS BERMAN, NATIONAL ...

      GlobeNewswire GlobeNewswire, over 1 year ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×